CLEVELAND, OH – October 14, 2010 -- Cervilenz Inc. has been selected to present the company's background, progress and future plans Tuesday, October 19, 2010 at AdvaMed 2010 in Washington, DC. The presentation will take place at 10:30 am in Room 204A at the Walter E. Washington Convention Center.
Cervilenz Inc. is currently introducing its innovative medical device – CerviLenz® – to the obstetrics
marketplace with great success. The first and only device of its kind, CerviLenz
is a simple, cost effective, disposable medical device that measures vaginal cervical length objectively. A short cervix during pregnancy is the best predictor of preterm birth risk.
Preterm birth can be a devastating pregnancy outcome, affecting over 12% of pregnancies in the United States
and the leading cause of infant mortality and morbidity. The Institute of Medicine estimates that the economic
cost of preterm birth in the United State is more than $26 billion annually.
"We look forward to sharing the CerviLenz story with the audience at AdvaMed 2010," said Dean Koch,
President and CEO. “Identifying pregnant women at risk of preterm birth is vital for delivering the right care at
the right time. Progesterone therapy is now emerging as an intervention for pregnant women with a short
cervix. CerviLenz is perfectly positioned to help clinicians quickly identify which pregnant women can benefit
from such therapy.”
About Cervilenz Inc.
Cervilenz Inc. is the manufacturer and distributor of CerviLenz®, a low cost, single use medical device that
measures vaginal cervical length. Dedicated to making a difference in the world of prematurity, CerviLenz Inc.
donates a portion of revenue to charitable organizations that advance maternal and fetal health worldwide.
The company headquarters is in the beautiful village of Chagrin Falls – a suburb of Cleveland, Ohio. For more
information, please visit cervilenz.com on contact Melanie Sweeney, Director of Marketing (440.337.4253 or
About AdvaMed 2010
AdvaMed 2010 is the premier MedTech conference for business leaders, entrepreneurs, policy-makers, media,
financiers, and other industry stakeholders from around the world. In only its third year, AdvaMed 2009
attracted 1,400 industry leaders – including 500+ CEOs, Presidents and C-level executives. In today’s
economic and political climate, AdvaMed 2010 is this year’s can’t miss MedTech event for networking;
conducting partnering meetings; influencing policymakers and the media; and participating in educational
sessions. Whether you need to finance, partner, or license technology; learn the latest important
developments in reimbursement, regulatory, legal, intellectual property, and other critical areas; or meet with
and hear from leaders in the Obama Administration and Congress, AdvaMed 2010 is your introduction to key
decision-makers. For more information, visit AdvaMed2010.com.